Data highlights PYLARIFY’s ability to detect recurrent prostate cancer in patients with low PSA
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
Seeking Alpha / 15 hours ago 2 Views
Seeking Alpha / 15 hours ago 2 Views
Data highlights PYLARIFY’s ability to detect recurrent prostate cancer in patients with low PSA
Comments